#ESCCongress – 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – SGLT2 inhibitors are now recommended for patients with heart failure with reduced ejection fraction regardless of the presence of diabetes.

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC – European Heart Journal

News release: ESC Guidelines on heart failure management launched today – European Society of Cardiology

Commentary on Twitter

The new heart failure guidelines by @escardio https://t.co/NRvxh8UUxp ready for #ESCCongress https://t.co/NlGYM9DAqA enjoy reading 128 pages. Some important figures pic.twitter.com/6GmRUuSw9z

— rafavidalperez (@rafavidalperez) August 27, 2021